All News
RheumNow Podcast – Sweet Lies or Hard Truths? (2.26.2021)
Dr. Jack Cush reviews and discusses the news and Journal reports from the past week on RheumNow.com.
Read Article
Measureable Benefits to Treat-to-Target Management in RA
Desai and colleagues have published that when a learning collaborative group focused on a treat‐to‐target approach was compared to usual care, a modest but significant impact on implementation, treatment changes and patient outcomes in RA patients managed with a treat‐to‐target approach was seen.
Read Article
RheumNow Podcast Available– Sweet Lies or Hard Truths
Available for download on Soundcloud, and Apple and Android devices.
https://t.co/undJYMoUOQ https://t.co/LzgvUUyoWs
Links:
Dr. John Cush RheumNow ( View Tweet)
How to reduce Zoom Burnout? - 4 tips from research:
1.Dont sit too close, and reduce monitor/image size
2. Avoid INFO overload
3. Move (think better when mobile)
4. Turn off Self view (avoid self evaluation)
https://t.co/Xi5Ha76D0t
Links:
Dr. John Cush RheumNow ( View Tweet)
QD Clinic - Periorbital Mass
Sarcoidosis with Dacroadenitis
https://t.co/Fat1ddRf7p https://t.co/3KbSFP8Lfb
Links:
Dr. John Cush RheumNow ( View Tweet)
News Feature: Measurable Benefits withTreat-to-Target Management in RA
https://t.co/iAvLWJGTXp https://t.co/XNtGhoWs5I
Links:
Dr. John Cush RheumNow ( View Tweet)
Single center, 40 yr experience shows lupus psychosis to be rare. Among 709 SLE pts, 18 (2.5%) developed lupus psychosis. 2/3 remitted w/ antipsychotics & immunosuppressives Psychosis more likely w/ RNP and less likely w/ cardiolipin Abs. https://t.co/XcRbxXz4zq
Links:
Dr. John Cush RheumNow ( View Tweet)
OR...when you come to RheumNow live - stock up on your new supply of RheumNow Pens https://t.co/UPyMur8GGn
Dr. John Cush RheumNow ( View Tweet)
Hey @RheumNow, my favorite pen died today... It’s been too long since I’ve seen you to re-stock. @KDAO2011 @TammyTilley https://t.co/1a1JRtMJ2v
Dr. Rachel Tate uptoTate ( View Tweet)
Psoriasis has greatest risk of MTX liver dz - a Danish Population study of PsO, PsA & RA pts taking MTX. Risk of liver Dz was most in PsO, followed by PsA, then RA. PsO had 1.6-3.4 fold risk (mild-severe) liver dz (vs RA). PsA was 1.3-1.6x higher) https://t.co/9YiGqVr66w
Links:
Dr. John Cush RheumNow ( View Tweet)
QD Clinic - Periorbital Edema
Dermatomyositis, Surprising Onset, Surprising Labs
https://t.co/KhXm10HoNV https://t.co/eRl4zUYQbh
Links:
Dr. John Cush RheumNow ( View Tweet)
We are excited to share that Roy Fleischmann will be leading a discussion on future therapy in RA at RheumnNow Live next month. Sign up today to attend in person or virtually.
https://t.co/vJlU0Z3Q3x https://t.co/uN1MrzWZA9
Links:
Dr. John Cush RheumNow ( View Tweet)
News Feature: ANAGO Study - Anakinra for Gout Flare
https://t.co/btP7ivMuPO https://t.co/HHsUKsjjuI
Links:
Dr. John Cush RheumNow ( View Tweet)
Other than anti-tRNA synthetase Abs, there are several new Abs associated with PM/DM @UTSWNews @UTSWInternalMed https://t.co/EttRB3YYHm
Dr. John Cush RheumNow ( View Tweet)
Classic path findings in dermatomyositis @UTSWNews @UTSWInternalMed https://t.co/W61OveDSwG
Dr. John Cush RheumNow ( View Tweet)
An unsual type of adult polymyositis that is not usually steroid responsive - Polymyositis with mitochondrial abnormalities - older patients +COX staining, slow progression. @UTSWNews @UTSWInternalMed https://t.co/2tv1R3e9Qg
Dr. John Cush RheumNow ( View Tweet)
Rheumatology Grand Rounds with Dr. Dennis Burns - lecturing on neuropathology of inflammatory myositis. Not all Muscle Bxs are positive, estimated sampling error w/ normal findings in 10-15%
@UTSWNews @UTSWInternalMed https://t.co/Xm73GuMa3j
Dr. John Cush RheumNow ( View Tweet)
A woman w/ Raynauds, puffy fingers, nailfold capillary changes, abundant mat telangiectases consistent with limited cutaneous systemic sclerosis. Telangiectasias can be on skin, oral mucosa, GI tract & may associate w/ pulm HTN. https://t.co/FcL4VHMpmM
Links:
Dr. John Cush RheumNow ( View Tweet)
New Video: Dry Eyes and Tripping Over Tires
RWCS 2021 Poster Session by Dr. Faizan Ahmad
https://t.co/9UymYbYcJ0
Links:
Dr. John Cush RheumNow ( View Tweet)
Cohort analysis of 12351 RA patients from CPRD registry - finds RA on both glucorticoids & PPI have a greater risk OP fractures (adj HR: 1.60, 95% CI: 1.35 to 1.89) vs non-use. Higher than the Fx Risk with either oral GC or PPI use alone (adj HR 1.2). https://t.co/oPMnJoHCjX https://t.co/eW7rpVeHa4
Links:
Dr. John Cush RheumNow ( View Tweet)